Cargando…
Free fatty acids induce ER stress and block antiviral activity of interferon alpha against hepatitis C virus in cell culture
BACKGROUND: Hepatic steatosis is recognized as a major risk factor for liver disease progression and impaired response to interferon based therapy in chronic hepatitis C (CHC) patients. The mechanism of response to interferon-alpha (IFN-α) therapy under the condition of hepatic steatosis is unexplor...
Autores principales: | Gunduz, Feyza, Aboulnasr, Fatma M, Chandra, Partha K, Hazari, Sidhartha, Poat, Bret, Baker, Darren P, Balart, Luis A, Dash, Srikanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490746/ https://www.ncbi.nlm.nih.gov/pubmed/22863531 http://dx.doi.org/10.1186/1743-422X-9-143 |
Ejemplares similares
-
SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells
por: Poat, Bret, et al.
Publicado: (2010) -
Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication
por: Poat, Bret, et al.
Publicado: (2010) -
Correction: SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells
por: Poat, Bret, et al.
Publicado: (2010) -
Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway
por: Hazari, Sidhartha, et al.
Publicado: (2010) -
Impaired Expression of Type I and Type II Interferon Receptors in HCV-Associated Chronic Liver Disease and Liver Cirrhosis
por: Chandra, Partha K., et al.
Publicado: (2014)